Keystone Heart Ltd. Announces First Patient Enrolled in New Study to Protect the Brain During TAVR


“The risk of stroke and other neurological damage is a very serious, yet potentially preventable complication associated with TAVR and other cardiovascular procedures,” said Study chair Jeffrey Moses, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, director of Interventional Cardiac Therapeutics at NewYork-Presbyterian Hospital/Columbia University Medical Center, and director of Advanced Cardiac Therapeutics at St. Francis Heart Center (Roslyn, NY). “Through research of devices such as TriGuard, we hope to prevent future TAVR patients from experiencing complications that can have a grave impact on how they are able to function in their daily lives.”

Read »

Created by keystoneheart 13 weeks 1 day ago – Made popular 12 weeks 5 days ago
Category: News   Tags:

BTC:  1BXApkUERv985SFnXrtrSxNSbm7qxhiHa5
LTC:   LbaPFdG5uaKe7bGQXcK5LAGFBKbfjT8sWp
ETH:  0xDfA4Bd2946C39907A9F82bd54a32d098678858dC
DASH:  XiaBkiG8GHt9PgXuGPfzg5MdAkZtiUz89H
DCR:  DsW4vSP5M5cx7TMWNCcgrUZb3w2kr4VUxY6

User login

EzySpot is a news/social bookmarking site.

Monetize Your Website


Syndicate content